Aβ oligomers inhibit synapse remodelling necessary for memory consolidation.

Neurobiology of Aging
Darragh B FreirCiaran M Regan

Abstract

Extensive research has implicated the amyloid-β protein (Aβ) in the aetiology of Alzheimer's disease (AD). This protein has been shown to produce memory deficits when injected into rodent brain and in mouse models of AD Aβ production is associated with impaired learning and/or recall. Here we examined the effects of cell-derived SDS-stable 7PA2-derived soluble Aβ oligomers on consolidation of avoidance learning. At 0, 3, 6, 9 or 12h after training, animals received an intracerebroventricular injection of Aβ-containing or control media and recall was tested at 24 and 48 h. Immediately after 48 h recall animals were transcardially perfused and the brain removed for sectioning and EM analysis. Rats receiving injections of Aβ at 6 or 9h post-training showed a significant impairment in memory consolidation at 48 h. Importantly, impaired animals injected at 9h had significantly fewer synapses in the dentate gyrus. These data suggest that Aβ low-n oligomers target specific temporal facets of consolidation-associated synaptic remodelling whereby loss of functional synapses results in impaired consolidation.

References

Nov 1, 1989·Pathology, Research and Practice·C Bertoni-FreddariJ Ulrich
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Jan 1, 1997·Neurobiology of Learning and Memory·T AlexinskyS J Sara
Aug 1, 1997·Journal of Neuropathology and Experimental Neurology·C I SzeL J Martin
May 20, 2003·The European Journal of Neuroscience·Mark D EyreMichael G Stewart
Jan 7, 2004·Nature Reviews. Neuroscience·Raphael Lamprecht, Joseph LeDoux
Sep 29, 2004·Neuron·Robert C Malenka, Mark F Bear
Sep 29, 2004·Neuron·Dominic M Walsh, Dennis J Selkoe
Dec 20, 2005·Lancet·Cleusa P FerriUNKNOWN Alzheimer's Disease International
Mar 17, 2006·Nature·Sylvain LesnéKaren H Ashe
Dec 19, 2006·Neurobiology of Learning and Memory·Diano F Marrone
Jul 25, 2008·Hippocampus·Jennifer CzerniawskiTim Otto
Apr 21, 2010·Brain : a Journal of Neurology·Jessica M Mc DonaldUNKNOWN Medical Research Council Cognitive Function and Ageing Study

❮ Previous
Next ❯

Citations

Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Andrei G VlassenkoMark A Mintun
Jun 22, 2012·International Journal of Alzheimer's Disease·Natalia Crespo-BielFred Van Leuven
Dec 3, 2013·Alzheimer's Research & Therapy·Eric Y Hayden, David B Teplow
Sep 18, 2012·PloS One·Rekha BhatClaudio Torres
Apr 22, 2014·Neurobiology of Aging·Katja S KrokerCornelia Dorner-Ciossek
Feb 19, 2011·International Journal of Alzheimer's Disease·David A Bateman, Avijit Chakrabartty
Jul 22, 2014·Alzheimer's Research & Therapy·William F GoureFranz Hefti
Feb 18, 2012·Neurobiology of Aging·Qinxi GuoNicholas John Justice
Oct 14, 2014·Neurological Research·Han-Chang HuangZhao-Feng Jiang
Nov 28, 2012·Neurobiology of Aging·Gilyana G BorlikovaDominic M Walsh
Jan 28, 2014·Biochemical Pharmacology·Cassia R Overk, Eliezer Masliah
Feb 12, 2013·Neurochemistry International·Ann TiimanVello Tõugu
Jan 27, 2015·Perspectives on Psychological Science : a Journal of the Association for Psychological Science·Michael K Scullin, Donald L Bliwise
Sep 8, 2017·Neuropathology and Applied Neurobiology·K E Ameen-AliJ Berwick
Feb 14, 2016·Cytoskeleton·James R Bamburg, Barbara W Bernstein
Dec 24, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ramcharan Singh AngomDebabrata Mukhopadhyay
Apr 10, 2014·The European Journal of Neuroscience·Stephanie AlfonsoRoberto Malinow
Jan 20, 2011·Journal of Neurochemistry·Kenjiro Ono, Masahito Yamada
Feb 16, 2011·Journal of Neurochemistry·Kumar SambamurtiMiguel A Pappolla
Jan 9, 2019·Frontiers in Cellular Neuroscience·Stephanie Ziegler-Waldkirch, Melanie Meyer-Luehmann
Jun 20, 2018·Alzheimer's Research & Therapy·Krystal HerlineThomas Wisniewski
May 10, 2018·Frontiers in Neuroscience·Isabelle L SumnerJessica L Teeling
Jul 25, 2019·Frontiers in Pharmacology·Claudia Balducci, Gianluigi Forloni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.